 Lorna Browne
Concepts (352)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 36 | 2025 | 3863 | 3.610 |
Why?
| | Tomography, X-Ray Computed | 21 | 2025 | 2730 | 3.110 |
Why?
| | Heart Defects, Congenital | 10 | 2025 | 914 | 2.320 |
Why?
| | Computed Tomography Angiography | 6 | 2025 | 145 | 1.890 |
Why?
| | Magnetic Resonance Angiography | 9 | 2025 | 251 | 1.890 |
Why?
| | Magnetic Resonance Imaging, Cine | 13 | 2025 | 214 | 1.750 |
Why?
| | Vascular Stiffness | 12 | 2024 | 486 | 1.740 |
Why?
| | Hemodynamics | 18 | 2025 | 1121 | 1.580 |
Why?
| | Aortic Coarctation | 5 | 2025 | 79 | 1.560 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 4 | 2022 | 91 | 1.290 |
Why?
| | Hypertension, Pulmonary | 9 | 2024 | 1980 | 1.280 |
Why?
| | Radiation Dosage | 4 | 2025 | 192 | 1.200 |
Why?
| | Coronary Angiography | 3 | 2025 | 323 | 1.100 |
Why?
| | Child | 57 | 2025 | 22633 | 1.080 |
Why?
| | Aorta | 12 | 2024 | 429 | 1.070 |
Why?
| | Pulmonary Artery | 12 | 2024 | 1134 | 1.050 |
Why?
| | Coronary Vessels | 5 | 2022 | 251 | 1.020 |
Why?
| | Heart | 6 | 2025 | 636 | 0.990 |
Why?
| | Tetralogy of Fallot | 6 | 2025 | 76 | 0.960 |
Why?
| | Infant | 27 | 2025 | 10034 | 0.950 |
Why?
| | Retrospective Studies | 35 | 2025 | 17066 | 0.890 |
Why?
| | Imaging, Three-Dimensional | 9 | 2025 | 583 | 0.880 |
Why?
| | Child, Preschool | 25 | 2025 | 11787 | 0.850 |
Why?
| | Infant, Newborn | 21 | 2025 | 6429 | 0.840 |
Why?
| | Blood Flow Velocity | 9 | 2024 | 413 | 0.780 |
Why?
| | Stenosis, Pulmonary Vein | 1 | 2023 | 19 | 0.770 |
Why?
| | Pulmonary Valve | 3 | 2024 | 101 | 0.760 |
Why?
| | Coronary Circulation | 3 | 2022 | 136 | 0.730 |
Why?
| | Heart Ventricles | 8 | 2023 | 760 | 0.720 |
Why?
| | Pulmonary Veins | 1 | 2023 | 105 | 0.720 |
Why?
| | Adolescent | 40 | 2025 | 22428 | 0.720 |
Why?
| | Humans | 96 | 2025 | 144759 | 0.680 |
Why?
| | Cardiac-Gated Imaging Techniques | 1 | 2020 | 21 | 0.650 |
Why?
| | Body Surface Area | 1 | 2020 | 35 | 0.640 |
Why?
| | Aorta, Thoracic | 5 | 2023 | 286 | 0.630 |
Why?
| | Ventricular Dysfunction, Left | 6 | 2020 | 392 | 0.630 |
Why?
| | Foreign Bodies | 1 | 2021 | 107 | 0.620 |
Why?
| | Heart Valve Prosthesis Implantation | 2 | 2024 | 197 | 0.590 |
Why?
| | Ventricular Function, Left | 6 | 2023 | 541 | 0.560 |
Why?
| | Photons | 4 | 2025 | 76 | 0.560 |
Why?
| | Anesthesia | 1 | 2022 | 258 | 0.550 |
Why?
| | Diagnostic Imaging | 2 | 2020 | 338 | 0.550 |
Why?
| | Glycogen Storage Disease | 1 | 2018 | 19 | 0.550 |
Why?
| | Osteomyelitis | 2 | 2012 | 143 | 0.540 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2023 | 410 | 0.530 |
Why?
| | Male | 52 | 2025 | 72315 | 0.530 |
Why?
| | Pulse Wave Analysis | 7 | 2022 | 266 | 0.530 |
Why?
| | Female | 53 | 2025 | 78271 | 0.520 |
Why?
| | Predictive Value of Tests | 8 | 2025 | 2115 | 0.520 |
Why?
| | Echocardiography | 6 | 2023 | 652 | 0.490 |
Why?
| | Bronchiolitis | 1 | 2017 | 87 | 0.480 |
Why?
| | Arteries | 1 | 2018 | 259 | 0.480 |
Why?
| | Scimitar Syndrome | 1 | 2016 | 9 | 0.480 |
Why?
| | Heart Rate | 1 | 2020 | 855 | 0.480 |
Why?
| | Postoperative Complications | 5 | 2020 | 2919 | 0.470 |
Why?
| | Hemoptysis | 1 | 2016 | 36 | 0.470 |
Why?
| | Staphylococcal Infections | 2 | 2012 | 388 | 0.460 |
Why?
| | Pregnancy Trimester, Third | 3 | 2025 | 115 | 0.460 |
Why?
| | Spermatocele | 1 | 2015 | 2 | 0.450 |
Why?
| | Phantoms, Imaging | 3 | 2025 | 158 | 0.450 |
Why?
| | Ultrasonography | 3 | 2015 | 770 | 0.450 |
Why?
| | Scrotum | 1 | 2015 | 24 | 0.440 |
Why?
| | Lymphangiectasis | 1 | 2014 | 4 | 0.440 |
Why?
| | Ventricular Dysfunction, Right | 5 | 2022 | 248 | 0.440 |
Why?
| | Lymphangiectasis, Intestinal | 1 | 2014 | 6 | 0.440 |
Why?
| | Lung Diseases, Interstitial | 2 | 2019 | 660 | 0.430 |
Why?
| | Cardiac Surgical Procedures | 4 | 2025 | 609 | 0.430 |
Why?
| | Image Enhancement | 2 | 2022 | 199 | 0.430 |
Why?
| | Myocardium | 2 | 2017 | 939 | 0.430 |
Why?
| | Pulmonary Valve Insufficiency | 3 | 2025 | 48 | 0.430 |
Why?
| | Testis | 1 | 2015 | 163 | 0.420 |
Why?
| | Pulmonary Atresia | 2 | 2025 | 22 | 0.410 |
Why?
| | Pancreatitis, Chronic | 2 | 2025 | 63 | 0.400 |
Why?
| | Fetal Heart | 2 | 2024 | 57 | 0.400 |
Why?
| | Cardiac Catheterization | 6 | 2025 | 560 | 0.400 |
Why?
| | Testicular Neoplasms | 1 | 2015 | 113 | 0.400 |
Why?
| | Heart Valve Diseases | 3 | 2024 | 151 | 0.390 |
Why?
| | Preoperative Care | 2 | 2017 | 379 | 0.390 |
Why?
| | Fontan Procedure | 3 | 2020 | 191 | 0.390 |
Why?
| | Stress, Mechanical | 5 | 2024 | 494 | 0.390 |
Why?
| | Arterial Pressure | 3 | 2019 | 136 | 0.380 |
Why?
| | Anesthesia, General | 2 | 2024 | 118 | 0.370 |
Why?
| | Community-Acquired Infections | 2 | 2012 | 174 | 0.360 |
Why?
| | Regional Blood Flow | 3 | 2024 | 514 | 0.360 |
Why?
| | Growth Plate | 1 | 2012 | 39 | 0.350 |
Why?
| | Pulmonary Circulation | 3 | 2025 | 430 | 0.350 |
Why?
| | Severe Combined Immunodeficiency | 1 | 2011 | 22 | 0.340 |
Why?
| | Aortic Valve | 3 | 2024 | 365 | 0.330 |
Why?
| | Intestinal Obstruction | 1 | 2011 | 56 | 0.330 |
Why?
| | Peritonitis | 1 | 2011 | 84 | 0.330 |
Why?
| | Contrast Media | 4 | 2025 | 488 | 0.330 |
Why?
| | Young Adult | 15 | 2024 | 14105 | 0.320 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2020 | 120 | 0.320 |
Why?
| | Lung Diseases | 2 | 2014 | 787 | 0.310 |
Why?
| | Myocardial Stunning | 1 | 2009 | 4 | 0.310 |
Why?
| | Aortic Diseases | 3 | 2020 | 124 | 0.310 |
Why?
| | Radiology | 2 | 2022 | 174 | 0.310 |
Why?
| | Coronary Vessel Anomalies | 1 | 2009 | 38 | 0.300 |
Why?
| | Aortic Arch Syndromes | 1 | 2009 | 2 | 0.300 |
Why?
| | Postoperative Care | 1 | 2011 | 288 | 0.300 |
Why?
| | Fetus | 3 | 2025 | 803 | 0.300 |
Why?
| | Reproducibility of Results | 10 | 2024 | 3409 | 0.290 |
Why?
| | Cardiology | 2 | 2022 | 353 | 0.290 |
Why?
| | Radiography, Abdominal | 2 | 2024 | 44 | 0.290 |
Why?
| | Heart Diseases | 2 | 2022 | 349 | 0.290 |
Why?
| | Diagnosis, Differential | 5 | 2018 | 1489 | 0.280 |
Why?
| | Technetium Tc 99m Medronate | 1 | 2008 | 4 | 0.280 |
Why?
| | Puberty, Precocious | 1 | 2008 | 12 | 0.280 |
Why?
| | Ultrasonography, Prenatal | 3 | 2025 | 294 | 0.270 |
Why?
| | Turner Syndrome | 2 | 2019 | 64 | 0.270 |
Why?
| | Ventricular Function, Right | 5 | 2022 | 297 | 0.270 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 103 | 0.270 |
Why?
| | Abnormalities, Multiple | 1 | 2009 | 197 | 0.270 |
Why?
| | Cardiovascular Diseases | 5 | 2025 | 2168 | 0.260 |
Why?
| | Hypothyroidism | 1 | 2008 | 67 | 0.260 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 2 | 2025 | 24 | 0.260 |
Why?
| | Ovary | 1 | 2008 | 228 | 0.240 |
Why?
| | Image Interpretation, Computer-Assisted | 3 | 2025 | 285 | 0.230 |
Why?
| | Perfusion Imaging | 3 | 2024 | 65 | 0.230 |
Why?
| | Abdominal Fat | 1 | 2025 | 50 | 0.230 |
Why?
| | Risk | 2 | 2018 | 911 | 0.220 |
Why?
| | Biopsy | 3 | 2018 | 1075 | 0.220 |
Why?
| | Artifacts | 2 | 2025 | 139 | 0.220 |
Why?
| | Greenhouse Gases | 1 | 2025 | 8 | 0.220 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2008 | 248 | 0.220 |
Why?
| | Echocardiography, Four-Dimensional | 1 | 2024 | 9 | 0.220 |
Why?
| | Treatment Outcome | 13 | 2025 | 11679 | 0.220 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2025 | 121 | 0.210 |
Why?
| | Respiration | 2 | 2022 | 206 | 0.210 |
Why?
| | Cross-Over Studies | 2 | 2024 | 601 | 0.210 |
Why?
| | Diabetes Mellitus, Type 1 | 4 | 2024 | 3890 | 0.210 |
Why?
| | Infant, Premature | 2 | 2023 | 611 | 0.210 |
Why?
| | Echocardiography, Doppler | 1 | 2024 | 115 | 0.210 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2025 | 2583 | 0.210 |
Why?
| | Gastrectomy | 1 | 2025 | 161 | 0.200 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2025 | 780 | 0.200 |
Why?
| | Health Resources | 1 | 2025 | 129 | 0.200 |
Why?
| | Gestational Age | 2 | 2024 | 975 | 0.200 |
Why?
| | T-Box Domain Proteins | 1 | 2024 | 106 | 0.190 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2024 | 197 | 0.190 |
Why?
| | Prenatal Diagnosis | 1 | 2025 | 195 | 0.190 |
Why?
| | Iothalamic Acid | 1 | 2022 | 5 | 0.190 |
Why?
| | Virtual Reality | 1 | 2024 | 77 | 0.180 |
Why?
| | Heart Valve Prosthesis | 1 | 2024 | 134 | 0.180 |
Why?
| | Hepatic Veins | 1 | 2021 | 32 | 0.170 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2025 | 299 | 0.170 |
Why?
| | Truncus Arteriosus | 1 | 2020 | 5 | 0.170 |
Why?
| | Vascular Malformations | 1 | 2021 | 50 | 0.170 |
Why?
| | Electric Power Supplies | 1 | 2021 | 52 | 0.170 |
Why?
| | Hemangiosarcoma | 1 | 2021 | 23 | 0.170 |
Why?
| | Pediatrics | 1 | 2009 | 1114 | 0.160 |
Why?
| | Case-Control Studies | 5 | 2019 | 3604 | 0.160 |
Why?
| | Heart Neoplasms | 1 | 2021 | 55 | 0.160 |
Why?
| | Portal Vein | 1 | 2021 | 114 | 0.160 |
Why?
| | Patient Compliance | 1 | 2024 | 588 | 0.160 |
Why?
| | Neoplasms, Second Primary | 1 | 2021 | 100 | 0.150 |
Why?
| | End Stage Liver Disease | 1 | 2021 | 94 | 0.150 |
Why?
| | Heart Function Tests | 1 | 2019 | 59 | 0.150 |
Why?
| | Sarcopenia | 1 | 2021 | 91 | 0.150 |
Why?
| | Gastric Bypass | 1 | 2021 | 125 | 0.150 |
Why?
| | Oxygen Consumption | 2 | 2025 | 724 | 0.150 |
Why?
| | Follow-Up Studies | 4 | 2021 | 5408 | 0.150 |
Why?
| | Sensitivity and Specificity | 3 | 2024 | 1985 | 0.150 |
Why?
| | Athetosis | 1 | 2019 | 7 | 0.150 |
Why?
| | Chemoradiotherapy | 1 | 2021 | 237 | 0.150 |
Why?
| | Congenital Hypothyroidism | 1 | 2019 | 10 | 0.150 |
Why?
| | Thyroid Nuclear Factor 1 | 1 | 2019 | 16 | 0.150 |
Why?
| | Chorea | 1 | 2019 | 13 | 0.150 |
Why?
| | Cardiovascular Abnormalities | 1 | 2019 | 15 | 0.150 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2020 | 139 | 0.140 |
Why?
| | Models, Cardiovascular | 1 | 2020 | 195 | 0.140 |
Why?
| | Kidney | 3 | 2022 | 1495 | 0.140 |
Why?
| | Marfan Syndrome | 1 | 2018 | 46 | 0.140 |
Why?
| | Eating | 1 | 2021 | 389 | 0.140 |
Why?
| | Cardiotonic Agents | 1 | 2018 | 95 | 0.140 |
Why?
| | Cloaca | 1 | 2018 | 52 | 0.140 |
Why?
| | Pulmonary Valve Stenosis | 1 | 2018 | 25 | 0.140 |
Why?
| | Pediatric Obesity | 1 | 2025 | 637 | 0.140 |
Why?
| | Urogenital Abnormalities | 1 | 2018 | 71 | 0.140 |
Why?
| | Shear Strength | 1 | 2018 | 72 | 0.140 |
Why?
| | Surgical Procedures, Operative | 1 | 2021 | 270 | 0.140 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2019 | 106 | 0.140 |
Why?
| | Thermodilution | 1 | 2017 | 15 | 0.130 |
Why?
| | Liver Function Tests | 1 | 2018 | 106 | 0.130 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2017 | 21 | 0.130 |
Why?
| | Obesity, Morbid | 1 | 2021 | 281 | 0.130 |
Why?
| | Blood Vessels | 1 | 2018 | 171 | 0.130 |
Why?
| | Cholangitis, Sclerosing | 1 | 2018 | 60 | 0.130 |
Why?
| | Stroke Volume | 4 | 2022 | 651 | 0.130 |
Why?
| | Thoracic Diseases | 1 | 2016 | 11 | 0.120 |
Why?
| | Sleep | 1 | 2024 | 901 | 0.120 |
Why?
| | Prospective Studies | 7 | 2024 | 7990 | 0.120 |
Why?
| | Vascular Remodeling | 1 | 2018 | 205 | 0.120 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2016 | 36 | 0.120 |
Why?
| | Perfusion | 1 | 2017 | 250 | 0.120 |
Why?
| | Dilatation, Pathologic | 3 | 2024 | 62 | 0.120 |
Why?
| | Systole | 3 | 2022 | 178 | 0.120 |
Why?
| | Prognosis | 5 | 2021 | 4282 | 0.120 |
Why?
| | Nitric Oxide | 1 | 2021 | 897 | 0.120 |
Why?
| | Aortic Valve Stenosis | 1 | 2019 | 253 | 0.120 |
Why?
| | Prevalence | 1 | 2023 | 2834 | 0.120 |
Why?
| | Adult | 12 | 2025 | 40449 | 0.110 |
Why?
| | Liver Cirrhosis | 1 | 2018 | 288 | 0.110 |
Why?
| | Quality Improvement | 1 | 2024 | 1289 | 0.110 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2022 | 630 | 0.110 |
Why?
| | Age Factors | 5 | 2024 | 3333 | 0.110 |
Why?
| | Fibrosis | 1 | 2017 | 548 | 0.110 |
Why?
| | Coronary Thrombosis | 1 | 2015 | 25 | 0.110 |
Why?
| | Metformin | 1 | 2018 | 318 | 0.110 |
Why?
| | Calcinosis | 1 | 2017 | 234 | 0.110 |
Why?
| | Mutation | 2 | 2024 | 4089 | 0.110 |
Why?
| | Exercise Test | 1 | 2017 | 634 | 0.110 |
Why?
| | Risk Assessment | 4 | 2018 | 3671 | 0.100 |
Why?
| | Toes | 1 | 2014 | 16 | 0.100 |
Why?
| | Surveys and Questionnaires | 2 | 2024 | 6048 | 0.100 |
Why?
| | Liver Transplantation | 1 | 2021 | 823 | 0.100 |
Why?
| | Research Design | 1 | 2020 | 1135 | 0.100 |
Why?
| | Arteriovenous Malformations | 1 | 2014 | 29 | 0.100 |
Why?
| | Disease Progression | 2 | 2018 | 2847 | 0.100 |
Why?
| | Edema | 1 | 2014 | 124 | 0.100 |
Why?
| | Vocal Cord Paralysis | 1 | 2012 | 27 | 0.090 |
Why?
| | Ligation | 1 | 2012 | 92 | 0.090 |
Why?
| | Reference Values | 2 | 2024 | 797 | 0.090 |
Why?
| | Comorbidity | 1 | 2017 | 1658 | 0.090 |
Why?
| | Surgical Instruments | 1 | 2012 | 51 | 0.090 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2012 | 50 | 0.090 |
Why?
| | Barium Sulfate | 1 | 2011 | 13 | 0.090 |
Why?
| | Gadolinium DTPA | 1 | 2012 | 68 | 0.090 |
Why?
| | North America | 2 | 2022 | 310 | 0.090 |
Why?
| | Biomechanical Phenomena | 3 | 2020 | 842 | 0.080 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1953 | 0.080 |
Why?
| | Lung | 2 | 2023 | 4109 | 0.080 |
Why?
| | Cross-Sectional Studies | 2 | 2024 | 5868 | 0.080 |
Why?
| | Colonography, Computed Tomographic | 1 | 2010 | 8 | 0.080 |
Why?
| | Bronchi | 1 | 2012 | 267 | 0.080 |
Why?
| | American Heart Association | 2 | 2022 | 350 | 0.080 |
Why?
| | Coronary Artery Disease | 1 | 2017 | 741 | 0.080 |
Why?
| | Glomerulonephritis, IGA | 1 | 2009 | 12 | 0.080 |
Why?
| | Myocardial Perfusion Imaging | 2 | 2020 | 49 | 0.080 |
Why?
| | Hypoglycemic Agents | 1 | 2018 | 1387 | 0.070 |
Why?
| | Ventricular Remodeling | 2 | 2022 | 276 | 0.070 |
Why?
| | Myocardial Contraction | 2 | 2020 | 298 | 0.070 |
Why?
| | Adnexal Diseases | 1 | 2008 | 2 | 0.070 |
Why?
| | Ovarian Cysts | 1 | 2008 | 6 | 0.070 |
Why?
| | Age Determination by Skeleton | 1 | 2008 | 16 | 0.070 |
Why?
| | Pericardial Effusion | 1 | 2008 | 22 | 0.070 |
Why?
| | Bacteremia | 1 | 2010 | 221 | 0.070 |
Why?
| | Thyroid Hormones | 1 | 2008 | 67 | 0.070 |
Why?
| | Pregnancy | 4 | 2025 | 7190 | 0.070 |
Why?
| | Radiopharmaceuticals | 1 | 2008 | 194 | 0.070 |
Why?
| | Thyroid Gland | 1 | 2008 | 88 | 0.070 |
Why?
| | Middle Aged | 6 | 2024 | 35875 | 0.060 |
Why?
| | Pleural Effusion | 1 | 2008 | 60 | 0.060 |
Why?
| | Myocardial Infarction | 1 | 2015 | 1209 | 0.060 |
Why?
| | Syndrome | 1 | 2008 | 380 | 0.060 |
Why?
| | Radiography, Thoracic | 1 | 2008 | 171 | 0.060 |
Why?
| | Pelvis | 1 | 2008 | 124 | 0.060 |
Why?
| | Puberty | 1 | 2008 | 140 | 0.060 |
Why?
| | Signal-To-Noise Ratio | 1 | 2025 | 73 | 0.060 |
Why?
| | Carbon Footprint | 1 | 2025 | 2 | 0.060 |
Why?
| | Blood Circulation | 1 | 2024 | 44 | 0.050 |
Why?
| | Motion | 1 | 2025 | 100 | 0.050 |
Why?
| | Hemorrhage | 1 | 2009 | 809 | 0.050 |
Why?
| | Aortic Aneurysm | 1 | 2024 | 70 | 0.050 |
Why?
| | Body Size | 1 | 2024 | 95 | 0.050 |
Why?
| | Time Factors | 3 | 2021 | 7173 | 0.050 |
Why?
| | Risk Factors | 4 | 2021 | 10779 | 0.050 |
Why?
| | Workflow | 1 | 2025 | 184 | 0.050 |
Why?
| | Actigraphy | 1 | 2024 | 145 | 0.050 |
Why?
| | Bromocriptine | 1 | 2022 | 31 | 0.050 |
Why?
| | Observer Variation | 1 | 2023 | 355 | 0.050 |
Why?
| | Iodine Radioisotopes | 1 | 2022 | 136 | 0.050 |
Why?
| | Climate Change | 1 | 2025 | 199 | 0.050 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2925 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 405 | 0.040 |
Why?
| | Prosthesis Design | 1 | 2024 | 357 | 0.040 |
Why?
| | Acute Kidney Injury | 1 | 2009 | 865 | 0.040 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2021 | 17 | 0.040 |
Why?
| | United States | 3 | 2024 | 15966 | 0.040 |
Why?
| | Creatinine | 1 | 2022 | 506 | 0.040 |
Why?
| | Adiposity | 1 | 2025 | 543 | 0.040 |
Why?
| | Iron-Binding Proteins | 1 | 2000 | 43 | 0.040 |
Why?
| | Indazoles | 1 | 2021 | 80 | 0.040 |
Why?
| | Norwood Procedures | 1 | 2020 | 29 | 0.040 |
Why?
| | Acute Disease | 1 | 2023 | 1030 | 0.040 |
Why?
| | Bevacizumab | 1 | 2021 | 167 | 0.040 |
Why?
| | Recurrence | 1 | 2023 | 1135 | 0.040 |
Why?
| | Patient-Specific Modeling | 1 | 2020 | 45 | 0.040 |
Why?
| | Cation Transport Proteins | 1 | 2000 | 118 | 0.040 |
Why?
| | Anti-Bacterial Agents | 1 | 2010 | 1907 | 0.040 |
Why?
| | Electrophysiological Phenomena | 1 | 2019 | 60 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2021 | 574 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2020 | 197 | 0.040 |
Why?
| | Diastole | 1 | 2019 | 143 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2020 | 150 | 0.040 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 80 | 0.040 |
Why?
| | Waiting Lists | 1 | 2021 | 263 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2024 | 2029 | 0.040 |
Why?
| | Biomarkers | 2 | 2022 | 4271 | 0.040 |
Why?
| | Autografts | 1 | 2019 | 55 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2022 | 760 | 0.040 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2018 | 75 | 0.040 |
Why?
| | Biliary Tract | 1 | 2018 | 14 | 0.030 |
Why?
| | Anastomosis, Surgical | 1 | 2018 | 157 | 0.030 |
Why?
| | Incidence | 2 | 2018 | 2879 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2021 | 1266 | 0.030 |
Why?
| | Societies, Medical | 1 | 2022 | 887 | 0.030 |
Why?
| | Vascular Resistance | 1 | 2019 | 367 | 0.030 |
Why?
| | Cardiovascular System | 1 | 2019 | 137 | 0.030 |
Why?
| | Electrophysiologic Techniques, Cardiac | 1 | 2018 | 84 | 0.030 |
Why?
| | Pyrimidines | 1 | 2021 | 532 | 0.030 |
Why?
| | Cardiac Output | 1 | 2017 | 179 | 0.030 |
Why?
| | Sulfonamides | 1 | 2021 | 580 | 0.030 |
Why?
| | Pilot Projects | 1 | 2022 | 1886 | 0.030 |
Why?
| | Algorithms | 1 | 2025 | 1837 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2000 | 737 | 0.030 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2015 | 56 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1720 | 0.030 |
Why?
| | Oxygen | 1 | 2018 | 995 | 0.020 |
Why?
| | Ultrasonography, Doppler | 1 | 2014 | 126 | 0.020 |
Why?
| | Tissue Plasminogen Activator | 1 | 2015 | 244 | 0.020 |
Why?
| | Triplets | 1 | 2012 | 3 | 0.020 |
Why?
| | Blood Pressure | 1 | 2019 | 1769 | 0.020 |
Why?
| | Pregnancy, Multiple | 1 | 2012 | 18 | 0.020 |
Why?
| | Fibrinolytic Agents | 1 | 2015 | 291 | 0.020 |
Why?
| | Angiography | 1 | 2012 | 208 | 0.020 |
Why?
| | Bronchoscopy | 1 | 2012 | 227 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2015 | 497 | 0.020 |
Why?
| | Ireland | 1 | 2010 | 32 | 0.020 |
Why?
| | Airway Obstruction | 1 | 2012 | 162 | 0.020 |
Why?
| | Cesarean Section | 1 | 2012 | 224 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2018 | 1241 | 0.020 |
Why?
| | Body Mass Index | 1 | 2018 | 2438 | 0.020 |
Why?
| | Endoscopy | 1 | 2012 | 316 | 0.020 |
Why?
| | Methylprednisolone | 1 | 2009 | 64 | 0.020 |
Why?
| | Reoperation | 1 | 2012 | 630 | 0.020 |
Why?
| | Liver | 1 | 2018 | 1887 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2015 | 1519 | 0.020 |
Why?
| | Obesity | 1 | 2021 | 3077 | 0.020 |
Why?
| | Pulmonary Alveoli | 1 | 2009 | 383 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2009 | 474 | 0.010 |
Why?
| | Renal Dialysis | 1 | 2009 | 462 | 0.010 |
Why?
| | Aged | 2 | 2019 | 25913 | 0.010 |
Why?
| | COS Cells | 1 | 2000 | 181 | 0.010 |
Why?
| | Gene Dosage | 1 | 2000 | 148 | 0.010 |
Why?
| | Plasmids | 1 | 2000 | 379 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2000 | 561 | 0.010 |
Why?
| | Transfection | 1 | 2000 | 940 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 8265 | 0.010 |
Why?
| | Rats | 1 | 2000 | 5597 | 0.010 |
Why?
| | Mice | 1 | 2000 | 18339 | 0.000 |
Why?
| | Animals | 1 | 2000 | 38058 | 0.000 |
Why?
|
|
Browne's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|